Concepedia

Raul H. Oyola

RH

Statistics

Publications

2

Citations

809

H-Index

2

Active since

2019

Affiliations

National University of La Rioja(Current)

Raul H. Oyola is an author at National University of La Rioja specializing in chemotherapy, oncology, and metastatic breast cancer treatment.

Publications per year

2019–2021

2

Publications

2

Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer

David Miles, Joseph Gligorov, Fabrice André et al. · Annals of Oncology · 2021 · 729 citations · Full text

, , +17

SOPHIA primary analysis: A phase 3 (P3) study of margetuximab (M) + chemotherapy (C) versus trastuzumab (T) + C in patients (pts) with HER2+ metastatic (met) breast cancer (MBC) after prior anti-HER2 therapies (Tx).

Hope S. Rugo, Seock‐Ah Im, Gail Lynn Shaw Wright et al. · Journal of Clinical Oncology · 2019 · 80 citations

, , +17

1–2 of 2